IgA antibodies in persisting Helicobacter pylori infection in Finnish adults

Most individuals infected with Helicobacter pylori have elevated levels of specific IgG antibodies, but only in about two-thirds of cases does the IgA titre exceed the cut-off level. The aim of this study was to determine whether H. pylori-infected subjects with elevated IgG levels would subsequentl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical microbiology and infection 2006-03, Vol.12 (3), p.236-240
Hauptverfasser: Salomaa-Räsänen, A., Kosunen, T.U., Karjalainen, J., Aromaa, A., Knekt, P., Sarna, S., Rautelin, H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 240
container_issue 3
container_start_page 236
container_title Clinical microbiology and infection
container_volume 12
creator Salomaa-Räsänen, A.
Kosunen, T.U.
Karjalainen, J.
Aromaa, A.
Knekt, P.
Sarna, S.
Rautelin, H.
description Most individuals infected with Helicobacter pylori have elevated levels of specific IgG antibodies, but only in about two-thirds of cases does the IgA titre exceed the cut-off level. The aim of this study was to determine whether H. pylori-infected subjects with elevated IgG levels would subsequently produce IgA antibodies, and whether elevated IgA levels increased during infection. Paired sera were available from 336 adults who took part in a large population-based health survey in 1977–1980 and a follow-up study on asthma and atopic diseases in 1997–1998 (series A). Data on paired sera from 224 adults who participated in a population-based health survey in Vammala, Finland in 1973 and who gave a follow-up blood sample in 1994 (series B) were also re-analysed. H. pylori IgG and IgA levels were determined with commercially available (series A) and in-house (series B) enzyme immunoassays. Twenty-one (35%) of the 60 subjects who initially had elevated levels of IgG antibodies only were found to be IgA-positive at follow-up. In those subjects whose baseline and follow-up samples were IgG- and IgA-positive, the median IgA levels increased by 48% and 22% in series A and B (p < 0.0001 and p 0.0241), respectively, whereas the median IgG levels did not change significantly in either series. During H. pylori infection, an increase in specific IgA was reflected by the increase in the number of responders and by the rise in titres.
doi_str_mv 10.1111/j.1469-0691.2005.01357.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67627504</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X14639161</els_id><sourcerecordid>17156922</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5377-43cf6e1dc07078be1cbae8809f71c889c7c751b45f123731310521d48f71924e3</originalsourceid><addsrcrecordid>eNqNkcFu1DAQhi0EoqXwCigXuCV4Yjt2DhzKitJKi7iAxM1ynEmZVdZZ7Cx03x6nu2qPxRePNN_vsT8zVgCvIK8Pmwpk05a8aaGqOVcVB6F0dfeMnT80nucaWlNqKX6esVcpbTjntRDyJTuDRiqQwM_Z-ub2snBhpm7qCVNBodhhTJRmCrfFNY7kp875GWOxO4xTpEwM6GeawsJeUQiUfhWu349zes1eDG5M-Oa0X7AfV5-_r67L9bcvN6vLdemV0LqUwg8NQu-55tp0CL5zaAxvBw3emNZrrxV0Ug1QCy1AAFc19NLkfltLFBfs_fHcXZx-7zHNdkvJ4zi6gNM-2UY3tVZcPgmCBtW0dZ1BcwR9nFKKONhdpK2LBwvcLsrtxi5m7WLWLsrtvXJ7l6NvTzP23Rb7x-DJcQbenQCXvBuH6IKn9MhpacC0C_fxyP2lEQ__fQG7Wn9dqpz_dMxjVv-HMNrkCYPHnmL-MdtP9PRr_gEAorB8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17156922</pqid></control><display><type>article</type><title>IgA antibodies in persisting Helicobacter pylori infection in Finnish adults</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Salomaa-Räsänen, A. ; Kosunen, T.U. ; Karjalainen, J. ; Aromaa, A. ; Knekt, P. ; Sarna, S. ; Rautelin, H.</creator><creatorcontrib>Salomaa-Räsänen, A. ; Kosunen, T.U. ; Karjalainen, J. ; Aromaa, A. ; Knekt, P. ; Sarna, S. ; Rautelin, H.</creatorcontrib><description>Most individuals infected with Helicobacter pylori have elevated levels of specific IgG antibodies, but only in about two-thirds of cases does the IgA titre exceed the cut-off level. The aim of this study was to determine whether H. pylori-infected subjects with elevated IgG levels would subsequently produce IgA antibodies, and whether elevated IgA levels increased during infection. Paired sera were available from 336 adults who took part in a large population-based health survey in 1977–1980 and a follow-up study on asthma and atopic diseases in 1997–1998 (series A). Data on paired sera from 224 adults who participated in a population-based health survey in Vammala, Finland in 1973 and who gave a follow-up blood sample in 1994 (series B) were also re-analysed. H. pylori IgG and IgA levels were determined with commercially available (series A) and in-house (series B) enzyme immunoassays. Twenty-one (35%) of the 60 subjects who initially had elevated levels of IgG antibodies only were found to be IgA-positive at follow-up. In those subjects whose baseline and follow-up samples were IgG- and IgA-positive, the median IgA levels increased by 48% and 22% in series A and B (p &lt; 0.0001 and p 0.0241), respectively, whereas the median IgG levels did not change significantly in either series. During H. pylori infection, an increase in specific IgA was reflected by the increase in the number of responders and by the rise in titres.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1111/j.1469-0691.2005.01357.x</identifier><identifier>PMID: 16451410</identifier><language>eng</language><publisher>Oxford, UK: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Antibodies ; Antibodies, Bacterial - blood ; Antibody Specificity ; Bacterial diseases ; Bacterial diseases of the digestive system and abdomen ; Biological and medical sciences ; Enzyme-Linked Immunosorbent Assay ; Female ; Finland - epidemiology ; Follow-Up Studies ; Helicobacter Infections - blood ; Helicobacter Infections - epidemiology ; Helicobacter pylori ; Helicobacter pylori - immunology ; Human bacterial diseases ; Humans ; IgA ; IgG ; Immunoglobulin A - blood ; Immunoglobulin A - immunology ; Immunoglobulin G - blood ; Infectious diseases ; Male ; Medical sciences ; Middle Aged ; Seroepidemiologic Studies ; serological tests ; seroprevalence</subject><ispartof>Clinical microbiology and infection, 2006-03, Vol.12 (3), p.236-240</ispartof><rights>2006 European Society of Clinical Infectious Diseases</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5377-43cf6e1dc07078be1cbae8809f71c889c7c751b45f123731310521d48f71924e3</citedby><cites>FETCH-LOGICAL-c5377-43cf6e1dc07078be1cbae8809f71c889c7c751b45f123731310521d48f71924e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1469-0691.2005.01357.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1469-0691.2005.01357.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17481890$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16451410$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salomaa-Räsänen, A.</creatorcontrib><creatorcontrib>Kosunen, T.U.</creatorcontrib><creatorcontrib>Karjalainen, J.</creatorcontrib><creatorcontrib>Aromaa, A.</creatorcontrib><creatorcontrib>Knekt, P.</creatorcontrib><creatorcontrib>Sarna, S.</creatorcontrib><creatorcontrib>Rautelin, H.</creatorcontrib><title>IgA antibodies in persisting Helicobacter pylori infection in Finnish adults</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>Most individuals infected with Helicobacter pylori have elevated levels of specific IgG antibodies, but only in about two-thirds of cases does the IgA titre exceed the cut-off level. The aim of this study was to determine whether H. pylori-infected subjects with elevated IgG levels would subsequently produce IgA antibodies, and whether elevated IgA levels increased during infection. Paired sera were available from 336 adults who took part in a large population-based health survey in 1977–1980 and a follow-up study on asthma and atopic diseases in 1997–1998 (series A). Data on paired sera from 224 adults who participated in a population-based health survey in Vammala, Finland in 1973 and who gave a follow-up blood sample in 1994 (series B) were also re-analysed. H. pylori IgG and IgA levels were determined with commercially available (series A) and in-house (series B) enzyme immunoassays. Twenty-one (35%) of the 60 subjects who initially had elevated levels of IgG antibodies only were found to be IgA-positive at follow-up. In those subjects whose baseline and follow-up samples were IgG- and IgA-positive, the median IgA levels increased by 48% and 22% in series A and B (p &lt; 0.0001 and p 0.0241), respectively, whereas the median IgG levels did not change significantly in either series. During H. pylori infection, an increase in specific IgA was reflected by the increase in the number of responders and by the rise in titres.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antibodies</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antibody Specificity</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the digestive system and abdomen</subject><subject>Biological and medical sciences</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Finland - epidemiology</subject><subject>Follow-Up Studies</subject><subject>Helicobacter Infections - blood</subject><subject>Helicobacter Infections - epidemiology</subject><subject>Helicobacter pylori</subject><subject>Helicobacter pylori - immunology</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>IgA</subject><subject>IgG</subject><subject>Immunoglobulin A - blood</subject><subject>Immunoglobulin A - immunology</subject><subject>Immunoglobulin G - blood</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Seroepidemiologic Studies</subject><subject>serological tests</subject><subject>seroprevalence</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcFu1DAQhi0EoqXwCigXuCV4Yjt2DhzKitJKi7iAxM1ynEmZVdZZ7Cx03x6nu2qPxRePNN_vsT8zVgCvIK8Pmwpk05a8aaGqOVcVB6F0dfeMnT80nucaWlNqKX6esVcpbTjntRDyJTuDRiqQwM_Z-ub2snBhpm7qCVNBodhhTJRmCrfFNY7kp875GWOxO4xTpEwM6GeawsJeUQiUfhWu349zes1eDG5M-Oa0X7AfV5-_r67L9bcvN6vLdemV0LqUwg8NQu-55tp0CL5zaAxvBw3emNZrrxV0Ug1QCy1AAFc19NLkfltLFBfs_fHcXZx-7zHNdkvJ4zi6gNM-2UY3tVZcPgmCBtW0dZ1BcwR9nFKKONhdpK2LBwvcLsrtxi5m7WLWLsrtvXJ7l6NvTzP23Rb7x-DJcQbenQCXvBuH6IKn9MhpacC0C_fxyP2lEQ__fQG7Wn9dqpz_dMxjVv-HMNrkCYPHnmL-MdtP9PRr_gEAorB8</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Salomaa-Räsänen, A.</creator><creator>Kosunen, T.U.</creator><creator>Karjalainen, J.</creator><creator>Aromaa, A.</creator><creator>Knekt, P.</creator><creator>Sarna, S.</creator><creator>Rautelin, H.</creator><general>Elsevier Ltd</general><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>200603</creationdate><title>IgA antibodies in persisting Helicobacter pylori infection in Finnish adults</title><author>Salomaa-Räsänen, A. ; Kosunen, T.U. ; Karjalainen, J. ; Aromaa, A. ; Knekt, P. ; Sarna, S. ; Rautelin, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5377-43cf6e1dc07078be1cbae8809f71c889c7c751b45f123731310521d48f71924e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antibodies</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antibody Specificity</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the digestive system and abdomen</topic><topic>Biological and medical sciences</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Finland - epidemiology</topic><topic>Follow-Up Studies</topic><topic>Helicobacter Infections - blood</topic><topic>Helicobacter Infections - epidemiology</topic><topic>Helicobacter pylori</topic><topic>Helicobacter pylori - immunology</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>IgA</topic><topic>IgG</topic><topic>Immunoglobulin A - blood</topic><topic>Immunoglobulin A - immunology</topic><topic>Immunoglobulin G - blood</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Seroepidemiologic Studies</topic><topic>serological tests</topic><topic>seroprevalence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salomaa-Räsänen, A.</creatorcontrib><creatorcontrib>Kosunen, T.U.</creatorcontrib><creatorcontrib>Karjalainen, J.</creatorcontrib><creatorcontrib>Aromaa, A.</creatorcontrib><creatorcontrib>Knekt, P.</creatorcontrib><creatorcontrib>Sarna, S.</creatorcontrib><creatorcontrib>Rautelin, H.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salomaa-Räsänen, A.</au><au>Kosunen, T.U.</au><au>Karjalainen, J.</au><au>Aromaa, A.</au><au>Knekt, P.</au><au>Sarna, S.</au><au>Rautelin, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IgA antibodies in persisting Helicobacter pylori infection in Finnish adults</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2006-03</date><risdate>2006</risdate><volume>12</volume><issue>3</issue><spage>236</spage><epage>240</epage><pages>236-240</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>Most individuals infected with Helicobacter pylori have elevated levels of specific IgG antibodies, but only in about two-thirds of cases does the IgA titre exceed the cut-off level. The aim of this study was to determine whether H. pylori-infected subjects with elevated IgG levels would subsequently produce IgA antibodies, and whether elevated IgA levels increased during infection. Paired sera were available from 336 adults who took part in a large population-based health survey in 1977–1980 and a follow-up study on asthma and atopic diseases in 1997–1998 (series A). Data on paired sera from 224 adults who participated in a population-based health survey in Vammala, Finland in 1973 and who gave a follow-up blood sample in 1994 (series B) were also re-analysed. H. pylori IgG and IgA levels were determined with commercially available (series A) and in-house (series B) enzyme immunoassays. Twenty-one (35%) of the 60 subjects who initially had elevated levels of IgG antibodies only were found to be IgA-positive at follow-up. In those subjects whose baseline and follow-up samples were IgG- and IgA-positive, the median IgA levels increased by 48% and 22% in series A and B (p &lt; 0.0001 and p 0.0241), respectively, whereas the median IgG levels did not change significantly in either series. During H. pylori infection, an increase in specific IgA was reflected by the increase in the number of responders and by the rise in titres.</abstract><cop>Oxford, UK</cop><pub>Elsevier Ltd</pub><pmid>16451410</pmid><doi>10.1111/j.1469-0691.2005.01357.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1198-743X
ispartof Clinical microbiology and infection, 2006-03, Vol.12 (3), p.236-240
issn 1198-743X
1469-0691
language eng
recordid cdi_proquest_miscellaneous_67627504
source MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adolescent
Adult
Antibodies
Antibodies, Bacterial - blood
Antibody Specificity
Bacterial diseases
Bacterial diseases of the digestive system and abdomen
Biological and medical sciences
Enzyme-Linked Immunosorbent Assay
Female
Finland - epidemiology
Follow-Up Studies
Helicobacter Infections - blood
Helicobacter Infections - epidemiology
Helicobacter pylori
Helicobacter pylori - immunology
Human bacterial diseases
Humans
IgA
IgG
Immunoglobulin A - blood
Immunoglobulin A - immunology
Immunoglobulin G - blood
Infectious diseases
Male
Medical sciences
Middle Aged
Seroepidemiologic Studies
serological tests
seroprevalence
title IgA antibodies in persisting Helicobacter pylori infection in Finnish adults
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T02%3A02%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IgA%20antibodies%20in%20persisting%20Helicobacter%20pylori%20infection%20in%20Finnish%20adults&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Salomaa-R%C3%A4s%C3%A4nen,%20A.&rft.date=2006-03&rft.volume=12&rft.issue=3&rft.spage=236&rft.epage=240&rft.pages=236-240&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1111/j.1469-0691.2005.01357.x&rft_dat=%3Cproquest_cross%3E17156922%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17156922&rft_id=info:pmid/16451410&rft_els_id=S1198743X14639161&rfr_iscdi=true